You are here

Planning Framework

The NBA has established a comprehensive planning framework (2013-16) as depicted in Figure 3.3.

Current programs include:

  • National Wastage Reduction
  • National Patient Blood Management Guidelines Implementation
  • National Blood Sector ICT Strategy
  • National Blood Sector Research and Development
  • National Blood Sector Data and Information
  • National Blood Education and Training
  • National Contract Development and Management
  • Ig Governance
  • Corporate Management and Governance.

NBA planning framework diagram

FIGURE 3.3 NBA Planning Framework

Progress against the Operational Plan is monitored and reported on by the Executive Group and the Chief Executive on a quarterly basis. The quarterly report on progress against key actions is provided to the NBA Board and Audit Committee.

In 2016-17, the NBA delivered 98 per cent of activities against the planned outcomes. Table 3.1 demonstrates the overall trend in the NBA's delivery against our operational plans over the past five years.

TABLE 3.1 NBA's performance in achieving operational plan objectives, 2011-12 to 2016-17

Year

2011-12

2012-13

2013-14

2014-15

2015-16

2016-17

Performance (%)

87%

91%

96%

91%

97%

98%

Key operational achievements for 2016-17 included the following:

  • the uninterrupted supply of blood and blood products to meet all clinical demand in accordance with the approved NSP&B
  • implemented new Deed of Agreement with the Australian Red Cross Society signed on 20 February 2016
  • Ig Governance program implemented and supports all supply authorisation for Ig, and new Ig governance system BloodSTAR implementation in all states and territories except NSW
  • worked with jurisdictional and clinical committees to develop the new PBM Implementation Strategy for 2017-21
  • commenced the redevelopment of BloodNet from the ground up to ensure the NBA improve speed and use of the system for the future. The redevelopment project, known as BloodNet 5, aims to release a range of enhancements, changes and improvements to the system
  • national blood sector research and development Round 2 grants awarded
  • continued collaborative work with the Australian Commission on Safety and Quality in Health Care (ACSQHC) on a review of the National Safety and Quality Health Service (NSQHS) Standards, Standard 7: Blood and Blood Products, and the completion of the National Patient Blood Management Collaborative, focussing on identification and management of pre-operative anaemia and iron deficiency
  • publication of a range of data reports including the Report on the Issue and Use of Intravenous Immunoglobulin (IVIg) 2015-16, Australian Haemovigilance Report and the Australian Bleeding Disorders Registry Annual Report 2015-16.
HTML version of this annual report converted and prepared by XiNG Digital Pty Ltd.